Genetic testing for early menopause in younger people
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This study looks at DNA changes to understand the cause of premature ovarian insufficiency (early menopause). It may help clarify what’s happening in your body and guide future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were diagnosed with premature ovarian insufficiency before age 38
- Your chromosome test is normal for 46,XX (and you do not have an FRM1 premutation)
- You have at least one sign your ovarian reserve is lower than expected for your age (like higher FSH, low AMH, or low AFC)
- Or, you previously had fertility treatment that did not respond well (few follicles or few eggs retrieved despite high-dose hormones)
- You have not had ovarian surgery or prior chemotherapy or radiation
- You do not have endometriosis, known autoimmune conditions, or certain metabolic diseases
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study aims to find genetic causes of certain types of infertility in men and women. If you have been diagnosed with very low sperm count, no sperm, or early ovarian failure, researchers will look at your DNA to discover new genes that might be responsible.
This study is looking for genetic markers that may help predict how chemotherapy affects the ovaries. It's for women who had breast cancer or lymphoma, froze their ovarian tissue before treatment, and finished that treatment at least 6 months ago.
This study looks at the genes that may cause premature ovarian insufficiency (POI), a condition where the ovaries stop working before age 40. The researchers will compare the genes of women with POI to those with normal ovarian function, which may lead to better understanding and future treatments.
This study follows women with premature ovarian insufficiency (POI) over time to understand how it affects their health. Researchers will collect samples and track health changes to learn more about the condition and its long-term effects.
This study looks at how certain blood markers relate to ovarian function in women with normal ovaries, diminished ovarian reserve (DOR), or primary ovarian insufficiency (POI). It may help doctors better understand these conditions.
This trial tests whether a hormone injection called HCG can activate dormant egg follicles in women under 40 who have gone through premature ovarian insufficiency (POI). If successful, it may help these women conceive.
Hear when a new Primary Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.